These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 22410027

  • 1. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.
    Choi HJ, Kim DG, Na GH, Hong TH, You YK.
    Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027
    [Abstract] [Full Text] [Related]

  • 2. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC.
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.
    Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, Ogawa K, Sakamoto S, Ogura Y, Egawa H, Tanaka K, Uemoto S.
    Liver Transpl; 2007 Dec; 13(12):1637-44. PubMed ID: 18044766
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.
    Transplantation; 2014 Jan 15; 97(1):71-7. PubMed ID: 24056623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW, Yi NJ, Suh KS.
    Transplantation; 2014 Apr 27; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [Abstract] [Full Text] [Related]

  • 15. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
    Na GH, Kim EY, Hong TH, You YK, Kim DG.
    HPB (Oxford); 2016 Jan 27; 18(1):98-106. PubMed ID: 26776857
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.
    Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, Ogawa K, Ogura Y, Oike F, Egawa H, Uemoto S.
    Dig Dis; 2007 Jan 27; 25(4):299-302. PubMed ID: 17960063
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.